Literature DB >> 2962580

High affinity binding of human interleukin 4 to cell lines.

H Cabrillat1, J P Galizzi, O Djossou, N Arai, T Yokota, K Arai, J Banchereau.   

Abstract

Purified human recombinant interleukin 4 (IL-4) was radio iodinated to high specific radioactivity without loss of biological activity. 125I-IL-4 bound specifically to the Burkitt lymphoma Jijoye cells and other cell lines. Jijoye cells showed a high affinity for 125I-IL-4 (Kd approximately equal to 7 10(-11) M) and displayed 1200-1400 specific receptors per cell at 4 degrees C or 37 degrees C. The equilibrium dissociation constant (Kd) corresponds to the IL-4 concentration which induces 50% maximal expression of the low affinity IgE receptor (Fc epsilon RL/CD23) on Jijoye cells. At 4 degrees C the rate constant of association K1 is 1.7 x 10(6) M-1 s-1 and the rate contant of dissociation k -1 is 1.3 x 10(-4) s-1 (t 1/2 = 91 min.) No human recombinant lymphokines other than IL-4 were able to compete for the binding of 125I-IL-4 to its receptor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2962580     DOI: 10.1016/0006-291x(87)90507-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  A microfilament formation inhibitor, cytochalasin strongly enhances the low-affinity Fc epsilon receptor II (CD23) expression on the human monocyte-like cell line, U937.

Authors:  N Ikewaki; H Tamauchi; A Yamada; M Aoki; R Yamamoto; A Sawada; H Inoko
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

2.  Localization of IL-4 and IL-4 receptors in the human term placenta, decidua and amniochorionic membranes.

Authors:  M I de Moraes-Pinto; G S Vince; B F Flanagan; C A Hart; P M Johnson
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

Review 3.  Cytokine networks in glioma.

Authors:  Kenichiro Iwami; Atsushi Natsume; Toshihiko Wakabayashi
Journal:  Neurosurg Rev       Date:  2011-06-09       Impact factor: 3.042

4.  Recombinant interleukin-4 promotes expression of the CD25 (Tac) antigen at the plasma membrane of high-density human tonsillar B lymphocytes.

Authors:  R D Butcher; G M McGarvie; W Cushley
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

5.  Purification and characterization of recombinant human interleukin 4. Biological activities, receptor binding and the generation of monoclonal antibodies.

Authors:  R Solari; D Quint; H Obray; A McNamee; E Bolton; P Hissey; B Champion; E Zanders; A Chaplin; B Coomber
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

6.  Hematopoietic growth factor receptors.

Authors:  J H Shieh; M A Moore
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

7.  Up-regulation of interleukin 4/B-cell stimulatory factor 1 receptor expression.

Authors:  J Ohara; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.

Authors:  N I Obiri; G G Hillman; G P Haas; S Sud; R K Puri
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

9.  Cytoplasmic and periplasmic expression of a highly basic protein, human interleukin 4, in Escherichia coli.

Authors:  D Lundell; R Greenberg; Y Alroy; R Condon; J D Fossetta; K Gewain; R Kastelein; C A Lunn; R Reim; C Shah
Journal:  J Ind Microbiol       Date:  1990-06

10.  Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement.

Authors:  N Kruse; H P Tony; W Sebald
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.